These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 25386750)

  • 41. The structural basis of function in Cys-loop receptors.
    Thompson AJ; Lester HA; Lummis SC
    Q Rev Biophys; 2010 Nov; 43(4):449-99. PubMed ID: 20849671
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Binding, activation and modulation of Cys-loop receptors.
    Miller PS; Smart TG
    Trends Pharmacol Sci; 2010 Apr; 31(4):161-74. PubMed ID: 20096941
    [TBL] [Abstract][Full Text] [Related]  

  • 43. An activity-based protein profiling probe for the nicotinic acetylcholine receptor.
    Tantama M; Lin WC; Licht S
    J Am Chem Soc; 2008 Nov; 130(47):15766-7. PubMed ID: 18975901
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Polymer-based open-channel blockers for the acetylcholine receptor: the effect of spacer length on blockade kinetics.
    Lin WC; Licht S
    Biochemistry; 2008 Sep; 47(35):9163-73. PubMed ID: 18690702
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Nanomolar CFTR inhibition by pore-occluding divalent polyethylene glycol-malonic acid hydrazides.
    Sonawane ND; Zhao D; Zegarra-Moran O; Galietta LJ; Verkman AS
    Chem Biol; 2008 Jul; 15(7):718-28. PubMed ID: 18635008
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Activation and block of the adult muscle-type nicotinic receptor by physostigmine: single-channel studies.
    Militante J; Ma BW; Akk G; Steinbach JH
    Mol Pharmacol; 2008 Sep; 74(3):764-76. PubMed ID: 18523135
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The therapy of congenital myasthenic syndromes.
    Engel AG
    Neurotherapeutics; 2007 Apr; 4(2):252-7. PubMed ID: 17395135
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Lamotrigine is an open-channel blocker of the nicotinic acetylcholine receptor.
    Vallés AS; Garbus I; Barrantes FJ
    Neuroreport; 2007 Jan; 18(1):45-50. PubMed ID: 17259859
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Binding of muscimol-conjugated quantum dots to GABAC receptors.
    Gussin HA; Tomlinson ID; Little DM; Warnement MR; Qian H; Rosenthal SJ; Pepperberg DR
    J Am Chem Soc; 2006 Dec; 128(49):15701-13. PubMed ID: 17147380
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Funny channels in the control of cardiac rhythm and mode of action of selective blockers.
    DiFrancesco D
    Pharmacol Res; 2006 May; 53(5):399-406. PubMed ID: 16638640
    [TBL] [Abstract][Full Text] [Related]  

  • 51. KATP channels as molecular sensors of cellular metabolism.
    Nichols CG
    Nature; 2006 Mar; 440(7083):470-6. PubMed ID: 16554807
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Paradigm shift in neuroprotection by NMDA receptor blockade: memantine and beyond.
    Lipton SA
    Nat Rev Drug Discov; 2006 Feb; 5(2):160-70. PubMed ID: 16424917
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Restoration of single-channel currents using the segmental k-means method based on hidden Markov modeling.
    Qin F
    Biophys J; 2004 Mar; 86(3):1488-501. PubMed ID: 14990476
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Activation and block of mouse muscle-type nicotinic receptors by tetraethylammonium.
    Akk G; Steinbach JH
    J Physiol; 2003 Aug; 551(Pt 1):155-68. PubMed ID: 12824448
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Treatment of slow-channel congenital myasthenic syndrome with fluoxetine.
    Harper CM; Fukodome T; Engel AG
    Neurology; 2003 May; 60(10):1710-3. PubMed ID: 12771277
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A re-examination of adult mouse nicotinic acetylcholine receptor channel activation kinetics.
    Salamone FN; Zhou M; Auerbach A
    J Physiol; 1999 Apr; 516 ( Pt 2)(Pt 2):315-30. PubMed ID: 10087333
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Spanning binding sites on allosteric proteins with polymer-linked ligand dimers.
    Kramer RH; Karpen JW
    Nature; 1998 Oct; 395(6703):710-3. PubMed ID: 9790193
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Quinidine sulfate therapy for the slow-channel congenital myasthenic syndrome.
    Harper CM; Engel AG
    Ann Neurol; 1998 Apr; 43(4):480-4. PubMed ID: 9546329
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Maximum likelihood estimation of aggregated Markov processes.
    Qin F; Auerbach A; Sachs F
    Proc Biol Sci; 1997 Mar; 264(1380):375-83. PubMed ID: 9107053
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Open channel and competitive block of the embryonic form of the nicotinic receptor of mouse myotubes by (+)-tubocurarine.
    Bufler J; Wilhelm R; Parnas H; Franke C; Dudel J
    J Physiol; 1996 Aug; 495 ( Pt 1)(Pt 1):83-95. PubMed ID: 8866353
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.